ARXS Arxis
Arxis earnings company data as of 4:47 AM ET 10/19
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.24 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ARXS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $5.6M bought by 7 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Ryan Anthony Jankowski Chief Accounting OfficerBuy$125K 4,464 shares at $28.00 +9.5% to stakeTraded Apr 17 Filed Apr 20
-
Azad Sid Badakhsh See RemarksBuy$1M 36,000 shares at $28.00 +9.8% to stakeTraded Apr 17 Filed Apr 20
-
Ross Bradley Sealfon See RemarksBuy$350K 12,500 shares at $28.00 +1.1% to stakeTraded Apr 17 Filed Apr 20
-
Stephen Duane Oetgen DirectorBuy$700K 25,000 shares at $28.00 +467% to stakeTraded Apr 17 Filed Apr 20
-
Patrick E Allen DirectorBuy$280K 10,000 shares at $28.00 +187% to stakeTraded Apr 17 Filed Apr 20
-
Kevin Scott Perhamus See RemarksBuy$1.5M 53,600 shares at $28.00 +1.5% to stakeTraded Apr 17 Filed Apr 20
-
Jason Aaron Roth See RemarksBuy$1.7M 60,000 shares at $28.00 +18% to stakeTraded Apr 17 Filed Apr 20
Also filed in the last 12 months, not counted as buying or selling: 11 stock grants.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 424B3 | Filing Doc | ||
| S-1 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.01,3.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,2.01,3.02,3.03,5.03,9.01 | Filing Doc | |
| 424B4 | Filing Doc | ||
| S-1/A | Filing Doc | ||
| S-1/A | Filing Doc | ||
| S-1 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.